Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityNo recent work listed

Jinfei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5874-3462; OpenAlex author ID A5000286768. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Use of period analysis to provide a timely assessment of 5-year relative survival for pancreatic cancer patients from Taizhou, eastern China. Last author DOI 10.1186/s12885-023-11119-3↗
  2. Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis. Last author DOI 10.3892/ol.2019.10281↗
  3. Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer. Co-author DOI 10.1093/jjco/hyv141↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ye Lu · 1 shared paper, 2023 · strength 0.19
  2. Tianhui Chen · 1 shared paper, 2023 · strength 0.19
  3. Jingsun Wei · 1 shared paper, 2019 · strength 0.09
  4. Cuiju Tang · 1 shared paper, 2015 · strength 0.06
  5. Chunxiang Cao · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.